Tags

Type your tag names separated by a space and hit enter

Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes.
Sci Rep. 2019 Nov 28; 9(1):18158.SR

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Authors+Show Affiliations

Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Karolinska Institutet/AstraZeneca Integrated CardioMetabolic Center (KI/AZ IC MC), Department of Medicine, Novum, Huddinge, Sweden.Pharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden. Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden. Institute of Computer Science, Polish Academy of Sciences, Warsaw, Poland.Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. claes.wadelius@igp.uu.se.

Pub Type(s)

Published Erratum

Language

eng

PubMed ID

31776441

Citation

Diamanti, Klev, et al. "Author Correction: Intra- and Inter-individual Metabolic Profiling Highlights Carnitine and Lysophosphatidylcholine Pathways as Key Molecular Defects in Type 2 Diabetes." Scientific Reports, vol. 9, no. 1, 2019, p. 18158.
Diamanti K, Cavalli M, Pan G, et al. Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Sci Rep. 2019;9(1):18158.
Diamanti, K., Cavalli, M., Pan, G., Pereira, M. J., Kumar, C., Skrtic, S., Grabherr, M., Risérus, U., Eriksson, J. W., Komorowski, J., & Wadelius, C. (2019). Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Scientific Reports, 9(1), 18158. https://doi.org/10.1038/s41598-019-54423-4
Diamanti K, et al. Author Correction: Intra- and Inter-individual Metabolic Profiling Highlights Carnitine and Lysophosphatidylcholine Pathways as Key Molecular Defects in Type 2 Diabetes. Sci Rep. 2019 Nov 28;9(1):18158. PubMed PMID: 31776441.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. AU - Diamanti,Klev, AU - Cavalli,Marco, AU - Pan,Gang, AU - Pereira,Maria J, AU - Kumar,Chanchal, AU - Skrtic,Stanko, AU - Grabherr,Manfred, AU - Risérus,Ulf, AU - Eriksson,Jan W, AU - Komorowski,Jan, AU - Wadelius,Claes, Y1 - 2019/11/28/ PY - 2019/11/29/entrez PY - 2019/11/30/pubmed PY - 2019/11/30/medline SP - 18158 EP - 18158 JF - Scientific reports JO - Sci Rep VL - 9 IS - 1 N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper. SN - 2045-2322 UR - https://www.unboundmedicine.com/medline/citation/31776441/Author_Correction:_Intra__and_inter_individual_metabolic_profiling_highlights_carnitine_and_lysophosphatidylcholine_pathways_as_key_molecular_defects_in_type_2_diabetes_ DB - PRIME DP - Unbound Medicine ER -